从精选的天然化合物中获得潜在的JAK2抑制剂:癌症患者补充疗法的有希望的方法
Samaneh Vaziri-Amjad1, Reza Rahgosha1, Amir Taherkhani2
1Department of Oral and Maxillofacial Medicine, School of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran.
这项研究确定了Janus激活激酶2 (JAK2) 的强有力的草药抑制剂,这是癌症的关键标. 东方素,脉素和酸显示强大的结合亲和力,为新的癌症药物开发提供了潜力.
科学领域:
- 生物化学 生物化学
- 计算化学计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 雅努斯激活酶2 (JAK2) 对于细胞增殖,细胞亡和转移至关重要.
- 抑制JAK2是一种有前途的癌症治疗策略.
- 这项研究研究了草药化合物作为潜在的JAK2抑制剂.
研究的目的:
- 选79种草药化合物,以确定它们与JAK2 ATP结合部位的结合亲和力.
- 为了确定JAK2.2的新型草本抑制剂.
- 评估这些化合物在癌症治疗中的潜力.
主要方法:
- 使用AutoDock 4.0和Cygwin进行分子对接.
- 与施罗丁格软件进行交叉验证.
- 用发现工作室可视化器进行分子动力学模拟和分析.
主要成果:
- 十二种黄酸,两种氨酸和三种酸显示出显著的结合 (ΔG结合<-10 kcal/mol).
- 东方素 (-14.49 kcal/mol),酸 (-11.87 kcal/mol) 和脉素 (-10.76 kcal/mol) 是最强大的抑制剂.
- 顶级抑制剂的接姿势在60秒模拟中保持稳定.
结论:
- 东方素,脉素和酸具有强大的JAK2抑制潜力.
- 这些化合物代表了开发新型抗癌药物的有希望的候选人.
- 进一步的研究可能会导致基于这些天然化合物的有效癌症治疗方法.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
